亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma

        2013-06-12 12:33:49AlexanderChiSijinWenNamNguyenGeraldineJacobsonScotRemickWilliamTseZhongxingLiao
        Chinese Journal of Cancer Research 2013年2期

        Alexander Chi, Sijin Wen, Nam P. Nguyen, Geraldine Jacobson, Scot Remick, William Tse, Zhongxing Liao

        1Department of Radiation Oncology, West Virginia University, Morgantown, WV 26506, USA;2Department of Biostatistics, West Virginia University, Morgantown, WV 26506, USA;3Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724, USA;4Mary Babb Randolph Cancer Center, Morgantown, WV 26506, USA;5Department of Hematology Oncology, West Virginia University, Morgantown, WV 26506, USA;6Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

        Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma

        Alexander Chi1, Sijin Wen2, Nam P. Nguyen3, Geraldine Jacobson1, Scot Remick4, William Tse5, Zhongxing Liao6

        1Department of Radiation Oncology, West Virginia University, Morgantown, WV 26506, USA;2Department of Biostatistics, West Virginia University, Morgantown, WV 26506, USA;3Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724, USA;4Mary Babb Randolph Cancer Center, Morgantown, WV 26506, USA;5Department of Hematology Oncology, West Virginia University, Morgantown, WV 26506, USA;6Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

        Corresponding to:Alexander Chi, M.D. Department of Radiation Oncology, West Virginia University 1 Medical Center Dr. Morgantown, WV 26505, USA. Email: achiaz2010@gmail.com.

        Submitted Jan 16, 2013. Accepted for publication Feb 19, 2013.

        Scan to your mobile device or view this article at:http://www.thecjcr.org/article/view/1507/2470

        Although declining in the US due to restrictions of asbestos exposure, malignant pleural mesothelioma (MPP) remains a very serious thoracic malignancy that is rising in incidence worldwide (1). Trimodality therapy with chemotherapy and radiotherapy combined with extrapleural pneumonectomy (EPP) has gained acceptance given the acceptable mortality rate (<5%) and long term survival reported in patients with epithelial histology, negative margins, and no extrapleural lymph node involvement after trimodality treatment (2). Since then, multiple studies have been published reported excellent median survival of >20 months after trimodality therapy (1). However, this treatment approach continues to be controversial given recent publications demonstrating that EPP may lead to poorer survival and increased mortality from surgery when compared with pleurectomy/ decortication (P/D) (3-5). As shown in a large retrospective review of patients who have undergone EPP or P/D, the operative mortality was found to be 7% after EPP and 4% after P/D with a hazard rate of 1.4 for EPP found after multivariate analysis (P<0.001) (3). In a non-randomized prospective study comparing EPP and P/D in the setting of trimodality therapy, prolonged median survival was observed after P/D, hyperthermic pleural lavage with povidone-iodine, and adjuvant chemotherapy and prophylactic radiotherapy when compared with neoadjuvant chemotherapy, EPP, and adjuvant radiotherapy (23vs. 12.8 months, P=0.004). Although improved survival is suggested, no conclusion regarding to whether EPP will lead to inferior survival when compared with P/D can be made due to the nature of these studies. In 2011, a prospective study (MARS) that attempts to compare EPP and P/D in a randomized fashion was reported (5). The aim of this study was to investigate the effect of EPP in the context of trimodality therapyvs. no EPP on the survival and quality of life in patients with malignant pleural mesothelioma. Due to the rarity of this disease, the feasibility of randomizing 50 patients in 1 year after neoadjuvant chemotherapy was explored. Among 112 patients registered between 2005 and 2008, 50 patients (T1-T3, N0-N1, and M0) were randomized to EPPvs. no EPP (24vs. 26). Among the 24 patients randomized to EPP, the procedure was only completed in 16 patients (3 total operative mortalities) and 8 of these 16 patients received radical radiotherapy afterwards. While no significant differences between groups were reported in the quality of life analyses, the hazard ratio for overall survival between the EPP and no EPP groups were 2.75 (P=0.016) after adjusting for sex, histological subtype, stage, and age at randomization. Although the data analysis was appropriate, the sample size is too small to make any conclusion regarding to patient survival after EPPvs. no EPP (power calculation was based on 670 patients). Also, the final conclusion of EPP shortens survival is not supported by statistical inference, but just based on the descriptive statistics. For example, a formal boundary (a cutoff of a statistic) in the interim analysis should be used to make a statistical inference or conclusion. Therefore, theconclusion of this study really needs to be interpreted with caution.

        More recently, a systematic review of trimodality therapy for malignant pleural mesothelioma has been conducted (6). Among the 16 studies included, the median survival ranged from 12.8 to 46.9 months and the perioperative mortality varied from 0 to 12.5% but mostly <5%. Large variation in median survival has been observed, but 6 studies reported median survival of ≥20 months. Given the current level of evidence, further studies need to be conducted to further investigate the effect of EPP on the survival of patients with malignant pleural mesothelioma, especially when advanced technology is applied in the delivery of adjuvant RT, which may potentially improve the survival of patients with malignant pleural mesothelioma in the setting of both EPP and P/D (7,8).

        Acknowledgements

        Disclosure:The authors declare no conflict of interest.

        1. Chi A, Liao Z, Nguyen NP, et al. Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol 2011;6:1132-41.

        2. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63; discussion 63-5.

        3. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-6, 626.e1-3.

        4. Lang-Lazdunski L, Bille A, Lal R, et al. Pleurectomy/ decortication in superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012;7:737-43.

        5. Treasure T, Lang-Lazdunski L, Waller D, et al. Extrapleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-72.

        6. Cao C, Tian D, Manganas C, et al. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg 2012;1:428-37.

        7. Tonoli S, Vitali P, Scotti V, et al. Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. Radiother Oncol 2011;101:311-5.

        8. Minatel E, Trovo M, Polesel J, et al. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol 2012;7:1862-6.

        Cite this article as:Chi A, Wen S, Nguyen NP, Jacobson G, Remick S, Tse W, Liao Z. Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma. Chin J Cancer Res 2013;25(2):128-129. doi: 10.3978/j.issn.1000-9604.2013.02.05

        10.3978/j.issn.1000-9604.2013.02.05

        日韩精品一二区在线视频| 国产成人精品999在线观看| 手机看片久久国产免费| 操B小视频国产| 日本视频在线观看一区二区| 成年女人a级毛片免费观看| 亚洲欧美日韩在线一区| 欧美日韩国产高清| 国产一区二区三区免费av| 日本丰满熟妇videossexhd | 伊人狼人影院在线视频| 国产一区二区三区啪| 91色区在线免费观看国产| 99视频在线精品免费观看6| 精品三级国产一区二区三| 麻豆蜜桃av蜜臀av色欲av| 精品人妻系列无码一区二区三区| 国产一线视频在线观看高清| 午夜蜜桃视频在线观看| 国内精品久久久久伊人av| 国产日韩欧美亚洲精品中字| 亚洲精品高清av在线播放| 成年人干逼视频水好多| 亚洲av无码国产精品色午夜字幕 | 东北无码熟妇人妻AV在线| 在线免费观看亚洲天堂av| 成人国产精品一区二区八戒网| 性大毛片视频| 久久精品视频91| 国产高清在线精品一区二区三区 | 日本一级片一区二区三区| 亚洲最大av网站在线观看| 亚洲综合欧美日本另类激情| 亚洲视频精品一区二区三区| 26uuu在线亚洲欧美| 精品久久久久久中文字幕| 色偷偷亚洲第一综合网| 国产精品成人一区二区不卡| 高清破外女出血av毛片| 亚洲欧美性另类春色| 日韩精品极品在线观看视频|